{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T13:37:34Z","timestamp":1788010654201,"version":"build-2784847793"},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:title>\n                    A\n                    <jats:sc>BSTRACT<\/jats:sc>\n                  <\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>\n                      The incidence of mycotic infections, especially of\n                      <jats:italic toggle=\"yes\">Candida<\/jats:italic>\n                      , has gradually increased over the past few years. In clinical practice, azoles are the most frequently used antifungal agents and the growing incidence of systemic candidiasis and resistance to antifungals have become a matter of concern worldwide. Virulence factors in\n                      <jats:italic toggle=\"yes\">Candida<\/jats:italic>\n                      spp. may be critical for predicting the response of antifungal drugs.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>\n                      This study aimed to identify the relationship between virulence factors and the antifungal susceptibility of\n                      <jats:italic toggle=\"yes\">Candida<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methodology:<\/jats:title>\n                    <jats:p>\n                      This cross-sectional study was conducted on a sample of 55\n                      <jats:italic toggle=\"yes\">Candida<\/jats:italic>\n                      strains isolated from vulvovaginal samples of patients in the reproductive age group, presenting with signs and symptoms of vulvovaginitis in a large tertiary care hospital in central India.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      A majority of the\n                      <jats:italic toggle=\"yes\">Candida<\/jats:italic>\n                      were sensitive to three tested drugs (89% to amphotericin B, 76.4% to fluconazole, and 89.1% to voriconazole). Resistance to fluconazole was highest at 16.4%. No significant relationships were identified between antifungal sensitivity of the three azoles with biofilm formation, phospholipase, or proteinase synthesis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>\n                      High level of antifungal resistance to the three antifungals, especially to voriconazole, is worrisome; however, none of the virulence markers have a significant association with antifungal sensitivity of\n                      <jats:italic toggle=\"yes\">Candida<\/jats:italic>\n                      species. This finding rules out the effect of the virulence of the pathogen on drug response.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jfmpc.jfmpc_1479_22","type":"journal-article","created":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T08:20:08Z","timestamp":1676535608000},"page":"152-159","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["A study of the association between virulence factors and antifungal susceptibility profile of Candida species recovered from cases of vulvovaginal candidiasis"],"prefix":"10.4103","volume":"12","author":[{"given":"Rafat","family":"Siddiqui","sequence":"first","affiliation":[{"name":"Microbiology, Mahaveer Institute of Medical Sciences and Research, Bhopal, MP, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak Kumar","family":"Mendiratta","sequence":"additional","affiliation":[{"name":"Department of Microbiology Jawaharlal Nehru Medical College and AVBRH, Sawangi (Meghe), Wardha, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aesha Farheen","family":"Siddiqui","sequence":"additional","affiliation":[{"name":"Family and Community Medicine, King Khalid University, Abha Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atul","family":"Rukadikar","sequence":"additional","affiliation":[{"name":"Department of Microbiology AIIMS Gorakhpur, Gorakhpur, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,2,15]]},"reference":[{"key":"R1-20240828","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3390\/jof3040057","article-title":"Global and Multi- National Prevalence of Fungal Diseases\u2014Estimate Precision","volume":"3","author":"Bongomin","year":"2017","journal-title":"J Fungi"},{"key":"R2-20240828","doi-asserted-by":"crossref","first-page":"615958","DOI":"10.1155\/2014\/615958","article-title":"Non-albicans candida infection:An emerging threat","volume":"2014","author":"Deorukhkar","year":"2014","journal-title":"Interdiscip Perspect Infect Dis"},{"key":"R3-20240828","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.micpath.2006.11.005","article-title":"Genetically regulated filamentation contributes to Candida albicans virulence during corneal infection","volume":"42","author":"Jackson","year":"2007","journal-title":"Microb Pathog"},{"key":"R4-20240828","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1128\/CMR.00076-09","article-title":"Candida infections of the genitourinary tract","volume":"23","author":"Achkar","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"R5-20240828","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1128\/EC.00034-10","article-title":"Adaptations of Candida albicans for growth in the mammalian intestinal tract","volume":"9","author":"Rosenbach","year":"2010","journal-title":"Eukaryot Cell"},{"key":"R6-20240828","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.micinf.2011.06.009","article-title":"Candida albicans interactions with epithelial cells and mucosal immunity","volume":"13","author":"Naglik","year":"2011","journal-title":"Microbes Infect"},{"key":"R7-20240828","doi-asserted-by":"crossref","first-page":"18026","DOI":"10.1038\/nrdp.2018.26","article-title":"Invasive Candidiasis","volume":"4","author":"Pappas","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"R8-20240828","doi-asserted-by":"crossref","first-page":"i4","DOI":"10.1093\/jac\/dkx444","article-title":"Changes in the epidemiological landscape of invasive candidiasis","volume":"73","author":"Lamoth","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"R9-20240828","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3390\/jof7050351","article-title":"Virulence factors and antifungal susceptibility profile of C. Tropicalis Isolated from various clinical specimens in Alexandria, Egypt","volume":"7","author":"El-Kholy","year":"2021","journal-title":"J Fungi"},{"key":"R10-20240828","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1007\/s10096-011-1455-z","article-title":"Insights into Candida tropicalis nosocomial infections and virulence factors","volume":"31","author":"Negri","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R11-20240828","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1590\/S1517-83822014005000018","article-title":"Use of the VITEK 2 system to identify and test the antifungal susceptibility of clinically relevant yeast species","volume":"44","author":"Melhem","year":"2013","journal-title":"Braz J Microbiol"},{"key":"R12-20240828","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3109\/1040841X.2010.489506","article-title":"Candida tropicalis in human disease","volume":"36","author":"Chai","year":"2010","journal-title":"Crit Rev Microbiol"},{"key":"R13-20240828","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/mmy\/myw028","article-title":"Analysis of virulence factors and in vivo biofilm-forming capacity of yarrowia lipolytica isolated from patients with fungemia","volume":"55","author":"Abbes","year":"2017","journal-title":"Med Mycology"},{"key":"R14-20240828","doi-asserted-by":"crossref","first-page":"8952878","DOI":"10.1155\/2017\/8952878","article-title":"Relationship between the antifungal susceptibility profile and the production of virulence-related hydrolytic enzymes in Brazilian clinical strains of candida glabrata","volume":"2017","author":"Figueiredo-Carvalho","year":"2017","journal-title":"Mediators Inflamm"},{"key":"R15-20240828","doi-asserted-by":"crossref","first-page":"713687","DOI":"10.1155\/2012\/713687","article-title":"Antifungal resistance and new strategies to control fungal infections","volume":"2012","author":"Vandeputte","year":"2012","journal-title":"Int J Microbiol"},{"key":"R16-20240828","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1574-6976.2011.00278.x","article-title":"Candida glabrata, Candida parapsilosis and Candida tropicalis:Biology, epidemiology, pathogenicity and antifungal resistance","volume":"36","author":"Silva","year":"2012","journal-title":"FEMS Microbiol Rev"},{"key":"R17-20240828","doi-asserted-by":"crossref","first-page":"foac019","DOI":"10.1093\/femsyr\/foac019","article-title":"The effect of antifungal resistance development on the virulence of Candida species","volume":"22","author":"Bohner","year":"2022","journal-title":"FEMS Yeast Res"},{"key":"R19-20240828","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1128\/JCM.00403-07","article-title":"Multicenter comparison of the VITEK 2 antifungal susceptibility test with the CLSI broth microdilution reference method for testing amphotericin B, flucytosine, and voriconazole against Candida spp","volume":"45","author":"Pfaller","year":"2007","journal-title":"J Clin Microbiol"},{"key":"R20-20240828","doi-asserted-by":"crossref","first-page":"27","DOI":"10.5152\/eajm.2011.06","article-title":"Investigating biofilm production, coagulase and hemolytic activity in candida species isolated from denture stomatitis patients","volume":"43","author":"Yigit","year":"2011","journal-title":"Eurasian J Med"},{"key":"R21-20240828","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S1130-1406(08)70050-0","article-title":"Proteninase and phospholipase activity as virulence factors in Candida species isolated from blood","volume":"25","author":"Mohan das","year":"2008","journal-title":"Rev Iberoam Micol"},{"key":"R22-20240828","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1099\/jmm.0.045054-0","article-title":"Candida species:Current epidemiology, pathology biofilm formation, natural anti-fungal products and new therapeutic options","volume":"62","author":"Sardi","year":"2013","journal-title":"J Med Microbiol"},{"key":"R23-20240828","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1186\/s12879-019-4588-9","article-title":"Surveillance study of the prevalence, species distribution, antifungal susceptibility, risk factors and mortality of invasive candidiasis in a tertiary teaching hospital in southwest China","volume":"19","author":"Zeng","year":"2019","journal-title":"BMC Infect Dis"},{"key":"R24-20240828","doi-asserted-by":"crossref","first-page":"3482","DOI":"10.1093\/jac\/dky353","article-title":"Effect of fluconazole prophylaxis on candida fluconazole susceptibility in premature infants","volume":"73","author":"Autmizguine","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"R25-20240828","doi-asserted-by":"crossref","first-page":"i14","DOI":"10.1093\/jac\/dkx445","article-title":"What has changed in the treatment of invasive candidiasis?A look at the past 10 years and ahead","volume":"73","author":"Bassetti","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"R26-20240828","doi-asserted-by":"crossref","first-page":"721439","DOI":"10.3389\/fcimb.2021.721439","article-title":"Molecular epidemiology, antifungal susceptibility, and virulence evaluation of candida isolates causing invasive infection in a tertiary care teaching hospital","volume":"11","author":"Chen","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"R27-20240828","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.20546\/ijcmas.2017.612.416","article-title":"Study of virulence markers and antifungal susceptibility by vitek-2 in various candida species isolated from cases of vulvovaginal candidiasis","volume":"6","author":"Siddiqi","year":"2017","journal-title":"Int J Curr Microbiol App Sci"},{"key":"R28-20240828","doi-asserted-by":"crossref","first-page":"624","DOI":"10.3855\/jidc.4186","article-title":"Characteristics and risk factors of candidemia in pediatric intensive care unit of a tertiary care children's hospital in Egypt","volume":"8","author":"Hegazi","year":"2014","journal-title":"J Infect Dev Ctries"},{"key":"R29-20240828","first-page":"1","article-title":"Species identification and antifungal susceptibility profile of candida isolates from ICU patients in Sohag University Hospital, Upper Egypt","volume":"38","author":"Esmat","year":"2015","journal-title":"Egypt J Med Microbiol"},{"key":"R30-20240828","doi-asserted-by":"crossref","first-page":"101","DOI":"10.12816\/0046235","article-title":"Automated identification and antifungal susceptibility testing of candida species using Vitek 2 compact system in ICUs and Pediatric Oncology Unit, Alexandria, Egypt","volume":"26","author":"Shawky","year":"2017","journal-title":"Egypt J Med Microbiol"},{"key":"R31-20240828","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1093\/jac\/dku460","article-title":"Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China:3 year national surveillance","volume":"70","author":"Xiao","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"R32-20240828","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.1128\/AAC.01035-13","article-title":"Antifungal susceptibilities of Candida isolates causing bloodstream infections at a medical center in Taiwan, 2009\u20132010","volume":"58","author":"Huang","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"R33-20240828","doi-asserted-by":"crossref","first-page":"34","DOI":"10.11604\/pamj.2022.41.34.30815","article-title":"Speciation and antifungal susceptibility of Candida isolates from diabetic foot ulcer patients in a tertiary hospital in Kenya","volume":"41","author":"Musyoki","year":"2022","journal-title":"Pan Afr Med J"},{"key":"R34-20240828","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jsps.2013.12.007","article-title":"The effect of antifungal combination on transcripts of a subset of drug-resistance genes in clinical isolates of Candida species induced biofilms","volume":"23","author":"Ibrahim NH Melake","year":"2015","journal-title":"Saudi Pharm J"},{"key":"R35-20240828","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/1469-0691.12440","article-title":"Candida species distribution and antifungal susceptibility testing according to European Committee on Antimicrobial Susceptibility Testing and new vs. old Clinical and Laboratory Standards Institute clinical breakpoints:A 6-year prospective candidaemia survey from the fungal infection network of Switzerland","volume":"20","author":"Orasch","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"R36-20240828","first-page":"1162","article-title":"Study on virulence factors of Candida tropicalis isolated from clinical samples","volume":"36","author":"Yu","year":"2015","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"key":"R37-20240828","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3109\/13693780902801242","article-title":"Enzymatic activities of Candida tropicalis isolated from hospitalized patients","volume":"48","author":"Galan-Ladero","year":"2010","journal-title":"Med Mycol"},{"key":"R38-20240828","doi-asserted-by":"crossref","first-page":"456878","DOI":"10.1155\/2014\/456878","article-title":"Virulence factors contributing to pathogenicity of candida tropicalis and its antifungal susceptibility profile","volume":"2014","author":"Deorukhkar","year":"2014","journal-title":"Int J Microbiol"},{"key":"R39-20240828","first-page":"548","article-title":"Adherence to buccal epithelial cells, enzymatic and haemolytic activities of Candida isolates from HIV-infected individuals","volume":"49","author":"Mane","year":"2011","journal-title":"Med Mycol"},{"key":"R40-20240828","first-page":"453","article-title":"Species distribution, virulence factors and antifungal susceptibility profile of Candida isolated from Oropharyngeal lesions of HIV infected patients","volume":"3","author":"Aher","year":"2014","journal-title":"Int J Curr Microbiol Appl Sci"},{"key":"R41-20240828","doi-asserted-by":"crossref","first-page":"142864","DOI":"10.1155\/2014\/142864","article-title":"Antifungal susceptibility patterns, in vitro production of virulence factors, and evaluation of diagnostic modalities for the speciation of pathogenic Candida from blood stream infections and vulvovaginal candidiasis","volume":"2014","author":"Tellapragada","year":"2014","journal-title":"J Pathog"},{"key":"R42-20240828","doi-asserted-by":"crossref","first-page":"475","DOI":"10.4103\/0377-4929.168873","article-title":"Comparison of biofilm formation in clinical isolates of Candida species in a tertiary care center, North India","volume":"58","author":"Agwan","year":"2015","journal-title":"Indian J Pathol Microbiol"},{"key":"R43-20240828","doi-asserted-by":"crossref","first-page":"e33705","DOI":"10.1371\/journal.pone.0033705","article-title":"Risk factors and outcomes of candidemia caused by biofilm-forming isolates in a tertiary care hospital","volume":"7","author":"Tumbarello","year":"2012","journal-title":"PLoS One"},{"key":"R44-20240828","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.ijmm.2014.08.012","article-title":"Production of biofilm by Candida and non-Candida spp. isolates causing fungemia:Comparison of biomass production and metabolic activity and development of cut-off points","volume":"304","author":"Marcos-Zambrano","year":"2014","journal-title":"Int J Med Microbiol"},{"key":"R45-20240828","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.eimc.2016.04.003","article-title":"Assessment of biofilm production in Candida isolates according to species and origin of infection","volume":"35","author":"Guembe","year":"2017","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"R46-20240828","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s11046-015-9964-4","article-title":"Candida tropicalis Biofilms:Biomass, metabolic activity and secreted aspartyl proteinase production","volume":"181","author":"Negri","year":"2016","journal-title":"Mycopathologia"},{"key":"R47-20240828","doi-asserted-by":"crossref","first-page":"112","DOI":"10.4103\/0255-0857.150909","article-title":"Biofilm as a virulence marker in Candida species in Nosocomial blood stream infection and its correlation with antifungal resistance","volume":"33","author":"Bhatt","year":"2015","journal-title":"Indian J Med Microbiol"},{"key":"R48-20240828","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.riam.2014.01.003","article-title":"Protease and phospholipase activities of Candida spp. isolated from cutaneous candidiasis","volume":"32","author":"Ramos Lde","year":"2015","journal-title":"Rev Iberoam Micol"},{"key":"R49-20240828","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.3390\/microorganisms10061208","article-title":"Continuing shifts in epidemiology and antifungal susceptibility highlight the need for improved disease management of invasive candidiasis","volume":"10","author":"Parslow","year":"2022","journal-title":"Microorganisms"},{"key":"R50-20240828","doi-asserted-by":"crossref","first-page":"dlac067","DOI":"10.1093\/jacamr\/dlac067","article-title":"Clinical utility of antifungal susceptibility testing","volume":"4","author":"McCarty","year":"2022","journal-title":"JAC Antimicrob Resist"}],"container-title":["Journal of Family Medicine and Primary Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_1479_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:06:05Z","timestamp":1787760365000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_1479_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_1479_22","relation":{},"ISSN":["2249-4863","2278-7135"],"issn-type":[{"value":"2249-4863","type":"print"},{"value":"2278-7135","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"2022-07-25","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-03","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}